Suppr超能文献

小儿心脏导管插入术后股动脉血栓形成的溶栓治疗。

Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization.

作者信息

Ino T, Benson L N, Freedom R M, Barker G A, Aipursky A, Rowe R D

机构信息

Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

出版信息

Am Heart J. 1988 Mar;115(3):633-9. doi: 10.1016/0002-8703(88)90815-0.

Abstract

Femoral artery thrombosis remains a well-known complication after cardiac catheterization. A study was undertaken to assess the efficacy of thrombolytic therapy for this complication. A total of 526 consecutive infants and children were prospectively evaluated after cardiac catheterization, and the medical charts of 42 patients who required femoral artery thrombectomy between 1975 and 1985 were reviewed. In the prospective study, patients were given a bolus injection of heparin, 150 U/kg, at the time the artery was entered. Patients with persistently absent or diminished pulse 2 hours after catheterization received a second bolus injection of 50 U/kg followed by an infusion of 20 U/kg/hr heparin for a maximum of 48 hours. If the affected leg pulse was absent or reduced and the systolic Doppler blood pressure was less than two thirds that of the unaffected leg, thrombolytic therapy was begun. In the 42 patients with surgical thrombectomy, there were no serious complications of surgery. Forty-five of the 526 patients (8.6%) had a decreased or absent pulse after catheterization. Of these 45 patients, 32 (71.1%) improved with systemic heparinization only. Thirteen patients (28.9%) had a persistently absent pedal pulse suggesting femoral artery thrombosis, despite continuous heparinization. Eleven patients were successfully treated with thrombolytic therapy and two required surgical thrombectomy. Intraarterial balloon dilatation procedures were performed in 8 of these 13 patients. Prothrombin time was prolonged (11.5 +/- 1.06 to 52.3 +/- 40.4 seconds; p less than 0.025) and fibrinogen levels were significantly reduced (2.25 +/- 0.79 to 1.52 +/- 0.52 gm/dl; p less than 0.01) during therapy. There were no serious complications, although four patients bled from the groin entry site.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

股动脉血栓形成仍是心脏导管插入术后一种广为人知的并发症。开展了一项研究以评估溶栓疗法对该并发症的疗效。对总共526例连续接受心脏导管插入术的婴幼儿和儿童进行了前瞻性评估,并回顾了1975年至1985年间42例需要进行股动脉血栓切除术患者的病历。在前瞻性研究中,在动脉穿刺时给予患者150 U/kg的肝素静脉推注。导管插入术后2小时脉搏持续消失或减弱的患者接受第二次50 U/kg的静脉推注,随后以20 U/kg/小时的速度输注肝素,最长持续48小时。如果患侧腿部脉搏消失或减弱且收缩期多普勒血压低于健侧腿部的三分之二,则开始溶栓治疗。在42例接受手术血栓切除术的患者中,没有严重的手术并发症。526例患者中有45例(8.6%)在导管插入术后出现脉搏减弱或消失。在这45例患者中,32例(71.1%)仅通过全身肝素化得到改善。13例患者(28.9%)尽管持续肝素化,但足部脉搏仍持续消失,提示股动脉血栓形成。11例患者通过溶栓治疗成功治愈,2例需要进行手术血栓切除术。这13例患者中有8例进行了动脉内球囊扩张术。治疗期间凝血酶原时间延长(从11.5±1.06秒延长至52.3±40.4秒;p<0.025),纤维蛋白原水平显著降低(从2.25±0.79克/分升降至1.52±0.52克/分升;p<0.01)。尽管有4例患者腹股沟穿刺部位出血,但没有严重并发症。(摘要截选至250词)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验